Abstract:Exosomes play a key role in colorectal cancer (CRC) related processes. This review explores the various functions of exosomes in CRC and their potential as diagnostic markers, therapeutic targets, and drug delivery vehicles. Exosomal long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) significantly influence CRC progression. Specific exosomal lncRNAs are linked to drug resistance and tumor growth, respectively, highlighting their therapeutic potential. Similarly, miRNAs like miR-21, miR-10b, and miR-92a-3p, carried by exosomes, contribute to chemotherapy resistance by altering signaling pathways and gene expression in CRC cells. The review also discusses exosomes' utility in CRC diagnosis. Exosomes from cancer cells have distinct molecular signatures compared to healthy cells, making them reliable biomarkers. Specific exosomal lncRNAs (e.g., CRNDE-h) and miRNAs (e.g., miR-17-92a) have shown effectiveness in early CRC detection and monitoring of treatment responses. Furthermore, exosomes show promise as vehicles for targeted drug delivery. The potential of mesenchymal stem cell (MSC)-derived exosomes in CRC treatment is also noted, with their role varying from promoting to inhibiting tumor progression. The application of multi-omics approaches to exosome research is highlighted, emphasizing the potential for discovering novel CRC biomarkers through comprehensive genomic, transcriptomic, proteomic, and metabolomic analyses. The review also explores the emerging field of exosome-based vaccines, which utilize exosomes' natural properties to elicit strong immune responses. In conclusion, exosomes represent a promising frontier in CRC research, offering new avenues for diagnosis, treatment, and prevention. Their unique properties and versatile functions underscore the need for continued investigation into their clinical applications and underlying mechanisms.

Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers

Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications

The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends

The Role of Extracellular Vesicles in Colorectal Cancer

An insight into small extracellular vesicles: Their roles in colorectal cancer progression and potential clinical applications

The Potential of Exosomes Derived from Colorectal Cancer As a Biomarker

Exosomes as potential sources of biomarkers in colorectal cancer

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers

Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression

Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers

Extracellular Vesicles in Inter-Kingdom Communication in Gastrointestinal Cancer.

Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy

Therapeutic and diagnostic applications of exosomes in colorectal cancer

Tumor exosome mediated immune regulation in colorectal cancer

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Tumor-derived extracellular vesicle proteins as new biomarkers and targets in precision oncology

Tumor‐derived exosomes: Potential biomarkers and therapeutic target in the treatment of colorectal cancer

Extracellular Vesicles in Cancer Therapy: Roles, Potential Application, and Challenges

Exosome: a New Perspective in Colorectal Cancer Therapy

Comparative proteomic analysis of three major extracellular vesicle classes secreted from human primary and metastatic colorectal cancer cells: Exosomes, microparticles, and shed midbody remnants